Prognostic value of metabolic tumor volume measured by FDG-PET/CT in patients with cervical cancer

2011 
Abstract Objective To determine if preoperative metabolic tumor volume (MTV) measured by integrated 18 F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (FDG-PET/CT) imaging has prognostic value in patients with cervical cancer treated primarily with radical hysterectomy. Methods Patients with FIGO stage IB to IIA cervical cancer were imaged with FDG-PET/CT before radical surgery. MTV was measured from attenuation-corrected FDG-PET/CT images using a standard uptake value (SUV)-based automated contouring program. We evaluated the relationship of MTV to disease-free survival (DFS). Results A total of 63 patients were included in the study. The cut-off value for predicting recurrence was determined using a receiver operating characteristic (ROC) curve. MTV in this study was found to be correlated with lymph node (LN) metastasis, parametrium (PM) involvement, FIGO stage, and SUV max . In univariate analysis, MTV≥23.4mL (HR 1.017, 95% confidence interval (CI) 1.005–1.029, P =0.004), SUV max ≥9.5 (HR 5.198, 95% CI 1.076–25.118, P =0.04), LN metastasis (HR 12.338, 95% CI 1.541–98.813, P =0.018), PM involvement (HR 14.274, 95% CI 1.785–114.149, P =0.012), and lymphovascular space invasion (HR 8.871, 95% CI 1.104–71.261, P =0.04), were related to DFS. In multivariate analyses, age (HR 0.748, 95% CI 0.587–0.952, P =0.018) and MTV≥23.4mL (HR 49.559, 95% CI 1.257–1953.399, P =0.037) were determined to be independent prognostic factors of DFS. Conclusion Preoperative MTV is an independent prognostic factor for DFS in patients with cervical cancer treated by radical surgery.
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    31
    References
    108
    Citations
    NaN
    KQI
    []